Autocitrullination of Human Peptidyl Arginine Deiminase Type 4 Regulates Protein Citrullination During Cell Activation

Overview

Journal Arthritis Rheum

Specialty Rheumatology

Date 2010 Mar 5

PMID 20201080

Citations 61

Authors

Felipe Andrade

Erika Darrah

Marjan Gucek

Robert N Cole

Antony Rosen

Xiaoming Zhu

Affiliations

Soon will be listed here.

Abstract

Objective: To address mechanisms that control the activity of human peptidyl arginine deiminase type 4 (PAD-4).

Methods: PAD-4 autocitrullination was determined by anti-modified citrulline immunoblotting, using purified recombinant and endogenous PAD-4 from activated human primary neutrophils and cell lines expressing PAD-4. The citrullination sites in PAD-4 were determined by mass spectrometry. Mechanisms of autocitrullination-induced inactivation and the functional consequences of autocitrullination in PAD-4 polymorphic variants were addressed using purified components and cell lines expressing PAD-4 wild-type, PAD-4 mutant, and PAD-4 polymorphic variants relevant to rheumatoid arthritis (RA).

Results: PAD-4 is autocitrullinated in vitro and during activation of primary cells and cell lines expressing PAD-4. Interestingly, this modification inactivated the function of the enzyme. The efficiency of inactivation differed among genetically defined PAD-4 variants relevant to RA. PAD-4 was citrullinated at 10 sites, which are clustered into 3 distinct regions, including a cluster of arginines around the active site cleft where Arg-372 and -374 were identified as the potential autocitrullination targets that inactivate the enzyme. Autocitrullination also modified the structure of PAD-4, abrogating its recognition by multiple rabbit antibodies, but augmenting its recognition by human anti-PAD-4 autoantibodies.

Conclusion: Our findings suggest that autocitrullination regulates the production of citrullinated proteins during cell activation, and that this is affected by structural polymorphisms in PAD-4. Autocitrullination also influences PAD-4 structure and immune response.

Citing Articles

Optogenetics with Atomic Precision─A Comprehensive Review of Optical Control of Protein Function through Genetic Code Expansion.

Charette M, Rosenblum C, Shade O, Deiters A Chem Rev. 2025; 125(4):1663-1717.

PMID: 39928721 PMC: 11869211. DOI: 10.1021/acs.chemrev.4c00224.

A cyclic peptide toolkit reveals mechanistic principles of peptidylarginine deiminase IV regulation.

Bertran M, Walmsley R, Cummings T, Aramburu I, Benton D, Mora Molina R Nat Commun. 2024; 15(1):9746.

PMID: 39528459 PMC: 11555231. DOI: 10.1038/s41467-024-53554-1.

Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung Disease.

Nava-Quiroz K, Lopez-Flores L, Perez-Rubio G, Rojas-Serrano J, Falfan-Valencia R Cells. 2023; 12(24).

PMID: 38132149 PMC: 10741699. DOI: 10.3390/cells12242829.

An unbiased proteomic analysis of PAD4 in human monocytes: novel substrates, binding partners and subcellular localizations.

Thomas M, Kim S, Curran A, Smith B, Antiochos B, Na C Philos Trans R Soc Lond B Biol Sci. 2023; 378(1890):20220477.

PMID: 37778379 PMC: 10542449. DOI: 10.1098/rstb.2022.0477.

Deimination in epidermal barrier and hair formation.

Mechin M, Simon M Philos Trans R Soc Lond B Biol Sci. 2023; 378(1890):20220245.

PMID: 37778378 PMC: 10542453. DOI: 10.1098/rstb.2022.0245.

References

Hagiwara T, Nakashima K, Hirano H, Senshu T, Yamada M . Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun. 2002; 290(3):979-83. DOI: 10.1006/bbrc.2001.6303. View

Shirai H, Blundell T, Mizuguchi K . A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem Sci. 2001; 26(8):465-8. DOI: 10.1016/s0968-0004(01)01906-5. View

Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M . Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet. 2003; 34(4):395-402. DOI: 10.1038/ng1206. View

Vossenaar E, Zendman A, van Venrooij W, Pruijn G . PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003; 25(11):1106-18. DOI: 10.1002/bies.10357. View

Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M . Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol. 2004; 11(8):777-83. DOI: 10.1038/nsmb799. View

Cuthbert G, Daujat S, Snowden A, Erdjument-Bromage H, Hagiwara T, Yamada M . Histone deimination antagonizes arginine methylation. Cell. 2004; 118(5):545-53. DOI: 10.1016/j.cell.2004.08.020. View

Wang Y, Wysocka J, Sayegh J, Lee Y, Perlin J, Leonelli L . Human PAD4 regulates histone arginine methylation levels via demethylimination. Science. 2004; 306(5694):279-83. DOI: 10.1126/science.1101400. View

Tarcsa E, Marekov L, Mei G, Melino G, Lee S, Steinert P . Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem. 1996; 271(48):30709-16. DOI: 10.1074/jbc.271.48.30709. View

Schellekens G, de Jong B, van den Hoogen F, van de Putte L, van Venrooij W . Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998; 101(1):273-81. PMC: 508564. DOI: 10.1172/JCI1316. View

10.

ROGERS G, Simmonds D . Content of citrulline and other amino-acids in a protein of hair follicles. Nature. 1958; 182(4629):186-7. DOI: 10.1038/182186a0. View

11.

ROGERS G . Occurrence of citrulline in proteins. Nature. 1962; 194:1149-51. DOI: 10.1038/1941149a0. View

12.

Chang X, Yamada R, Suzuki A, Sawada T, Yoshino S, Tokuhiro S . Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford). 2004; 44(1):40-50. DOI: 10.1093/rheumatology/keh414. View

13.

Doyle H, Mamula M . Posttranslational modifications of self-antigens. Ann N Y Acad Sci. 2005; 1050:1-9. DOI: 10.1196/annals.1313.001. View

14.

Takizawa Y, Sawada T, Suzuki A, Yamada R, Inoue T, Yamamoto K . Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis. Scand J Rheumatol. 2005; 34(3):212-5. DOI: 10.1080/03009740510026346-1. View

15.

Plenge R, Padyukov L, Remmers E, Purcell S, Lee A, Karlson E . Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005; 77(6):1044-60. PMC: 1285162. DOI: 10.1086/498651. View

16.

Kang C, Lee H, Ju H, Cho H, Kang C, Bae S . A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. 2005; 54(1):90-6. DOI: 10.1002/art.21536. View

17.

Arita K, Shimizu T, Hashimoto H, Hidaka Y, Yamada M, Sato M . Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4. Proc Natl Acad Sci U S A. 2006; 103(14):5291-6. PMC: 1459348. DOI: 10.1073/pnas.0509639103. View

18.

Hoppe B, Haupl T, Gruber R, Kiesewetter H, Burmester G, Salama A . Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study. Arthritis Res Ther. 2006; 8(2):R34. PMC: 1526594. DOI: 10.1186/ar1889. View

19.

Thompson P, Fast W . Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock?. ACS Chem Biol. 2006; 1(7):433-41. DOI: 10.1021/cb6002306. View

20.

Matsuo K, Xiang Y, Nakamura H, Masuko K, Yudoh K, Noyori K . Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther. 2006; 8(6):R175. PMC: 1794520. DOI: 10.1186/ar2085. View